| 486 |
Binding to the extracellular protein laminin leading to decreased cognitive function |
Eliska Kuchovska |
BY-SA |
2109: Binding, extracellular matrix protein laminin
|
402: Cognitive function, decreased
|
|
|
| 487 |
Unknown MIE altering cholesterol metabolism leading to decreased cognition |
Eliska Kuchovska |
BY-SA |
1114: Unknown, MIE
|
402: Cognitive function, decreased
|
|
|
| 488 |
Increased reactive oxygen species production leading to decreased cognitive function |
Eliska Kuchovska |
BY-SA |
1115: Increase, Reactive oxygen species
|
402: Cognitive function, decreased
|
|
|
| 489 |
Inhibition of voltage-gated sodium channels leading to decreased cognition |
Eliska Kuchovska |
BY-SA |
1353: Binding to voltage-gated sodium channel
|
402: Cognitive function, decreased
|
|
|
| 490 |
Co-activation of IP3R and RyR leads to reduced IQ and increased socio-economic burden through non-cholinergic mechanisms |
Karine Audouze |
All rights reserved |
2 MIEs
|
3 AOs
|
|
|
| 491 |
Decrease, GLI1/2 target gene expression leads to orofacial clefting |
Jacob Reynolds |
All rights reserved |
2040: Decrease, GLI1/2 target gene expression
|
2042: Increase, Orofacial clefting
|
Under Development |
1.101 |
| 492 |
Glutathione conjugation leading to reproductive dysfunction via oxidative stress |
Leonardo Vieira |
All rights reserved |
2131: Conjugation, GSH
|
406: decreased, Fertility
|
|
|
| 493 |
ERa inactivation alters AT expansion and functions and leads to insulin resistance and metabolically unhealthy obesity |
Min Ji Kim |
All rights reserved |
2126: Estrogen receptor alpha inactivation
|
2129: Metabolically unhealthy Obesity
|
|
|
| 494 |
AhR activation leading to liver fibrosis |
Xavier COUMOUL |
BY-SA |
18: Activation, AhR
|
344: Increase, Liver fibrosis
|
|
|
| 495 |
Androgen receptor activation leading to prostate cancer |
Jianxiang Li |
All rights reserved |
25: Agonism, Androgen receptor
|
2135: Prostate cancer
|
|
|
| 496 |
Androgen receptor agonism leading to reproduction dysfunction (in zebrafish) |
Hongling Liu |
BY-SA |
25: Agonism, Androgen receptor
|
442: Decreased, Population trajectory
|
|
|
| 497 |
ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome |
Min Ji Kim |
All rights reserved |
2126: Estrogen receptor alpha inactivation
|
2 AOs
|
|
|
| 498 |
Increased LCN2/iron complex leading to neurological disorders |
Young Jun Kim |
Open for adoption |
2148: Increased LCN2/iron complex binds to SLC22A17 receptor in neuron
|
2150: Neurological disorder
|
|
|
| 499 |
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release |
Travis Karschnik |
All rights reserved |
2146: Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2
|
341: Impairment, Learning and memory
|
|
|
| 500 |
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis |
Travis Karschnik |
All rights reserved |
2146: Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2
|
341: Impairment, Learning and memory
|
|
|
| 501 |
Excessive iron accumulation leading to neurological disorders |
Young Jun Kim |
Open for adoption |
2149: Increased intracelluar Iron accumulation
|
2150: Neurological disorder
|
|
|
| 502 |
Decrease, cholesterol synthesis leads to orofacial clefting |
Jacob Reynolds |
All rights reserved |
None
|
2042: Increase, Orofacial clefting
|
Under Development |
1.101 |
| 503 |
Activation of uterine estrogen receptor-alfa leading to endometrial adenocarcinoma, via epigenetic modulation |
Barbara Viviani |
BY-SA |
1065: Activation, estrogen receptor alpha
|
2154: Uterine adenocarcinoma (endometrioid adenocarcinoma Type I)
|
Under Review |
1.100 |
| 504 |
SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level |
Martina Panzarea |
All rights reserved |
2155: Inhibition of Sulfotransferase E1 (SULT1E1)
|
1065: Activation, estrogen receptor alpha
|
|
|
| 505 |
Reactive Oxygen Species (ROS) formation leads to cancer via inflammation pathway |
John Frisch |
BY-SA |
1115: Increase, Reactive oxygen species
|
885: Increase, Cancer
|
|
|
| 506 |
Binding of Influenza A Virus (IAV) to Sialic Acid Glycan Receptor leads to viral infection proliferation |
Jessica Resnick |
All rights reserved |
2158: Influenza A Virus (IAV) binds sialic acid glycan receptor
|
2194: Influenza A Virus (IAV) shedding and transmission
|
|
|
| 507 |
Nrf2 inhibition leading to vascular disrupting effects via inflammation pathway |
Yanhong Wei |
All rights reserved |
1417: NFE2/Nrf2 repression
|
2161: Increase, Vascular disrupting effects
|
|
|
| 508 |
Nrf2 inhibition leading to vascular disrupting effects through activating HIF1α, Semaphorin 6A, and Dll4-Notch pathway |
Yanhong Wei |
All rights reserved |
1417: NFE2/Nrf2 repression
|
2161: Increase, Vascular disrupting effects
|
|
|
| 509 |
Nrf2 inhibition leading to vascular disrupting effects through activating apoptosis signal pathway and mitochondrial dysfunction |
Yanhong Wei |
All rights reserved |
1417: NFE2/Nrf2 repression
|
2161: Increase, Vascular disrupting effects
|
|
|
| 510 |
Demethylation of PPAR promotor leading to vascular disrupting effects |
Yanhong Wei |
All rights reserved |
228: peroxisome proliferator activated receptor promoter demethylation
|
2161: Increase, Vascular disrupting effects
|
|
|